15 April 2025
Nykode Announces that Michael Engsig, CEO; Agnete Fredriksen, CSO ...
Read More
Unlocking
the future
of medicine
About us
Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart
PipelineReducing the impact of cancer and autoimmune diseases on people’s lives is why we’re here
Research and developmentPushing the boundaries of human advancement in medicine is what drives us every day
InvestorsAn immunotherapy platform that unlocks unlimited possibilities for the future of medicine
The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ immunotherapy has the potential to treat many disease areas, including cancer.
